# Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary Dissection

> **NCT00123799** · PHASE2 · TERMINATED · sponsor: **AHS Cancer Control Alberta** · enrollment: 199 (actual)

## Conditions studied

- Breast Neoplasms

## Interventions

- **PROCEDURE:** Positron Emission Tomography Imaging

## Key facts

- **NCT ID:** NCT00123799
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-06
- **Primary completion:** —
- **Final completion:** 2007-04
- **Target enrollment:** 199 (ACTUAL)
- **Why stopped:** sufficient enrollment reached
- **Last updated:** 2024-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00123799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00123799, "Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary Dissection". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT00123799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*